Fox Chase Cancer Center
Fox Chase Cancer Center is a National Cancer Institute-designated Comprehensive Cancer Center located in the Fox Chase neighborhood of Northeast Philadelphia. Founded in 1904, Fox Chase has been a leader in cancer research and treatment, with discoveries including the link between genetics and cancer that earned researchers the Nobel Prize. The center joined Temple Health in 2012, combining academic cancer research with the health system's clinical capabilities.[1]
History
Fox Chase Cancer Center traces its origins to the American Oncologic Hospital, founded in 1904 as one of the nation's first cancer specialty hospitals. Back then, cancer was poorly understood and often incurable. Yet this institution focused exclusively on cancer care and research when that commitment was genuinely unusual. The hospital's dedication to cancer specialization continued through the twentieth century as understanding of the disease expanded dramatically and treatment options improved.[1]
In 1927, they established the Institute for Cancer Research, which quickly became a leading center for basic cancer work. Scientists there made fundamental discoveries about cell biology, genetics, and cancer mechanisms. What distinguished Fox Chase was the combination: it wasn't just a treatment hospital, it was a research institution. That integrated approach set it apart.[1]
Everything changed in 1974. The American Oncologic Hospital and the Institute for Cancer Research merged to create Fox Chase Cancer Center, finally bringing clinical and research missions under one roof. The NCI's Comprehensive Cancer Center designation followed, recognizing the institution's combined excellence in research, treatment, education, and community outreach. Today, only about fifty centers nationwide hold this designation.[1]
Nobel Prize Research
Fox Chase's most celebrated scientific achievement was the 1976 Nobel Prize in Physiology or Medicine awarded to Baruch Blumberg for discovering the Hepatitis B virus and developing a vaccine. He did this work at the Institute for Cancer Research, demonstrating unexpected connections between infectious disease and cancer research. The hepatitis B vaccine has prevented millions of liver cancer cases worldwide.[1]
Years earlier, scientists including Peter Nowell and David Hungerford made another breakthrough. They discovered the Philadelphia chromosome—named for the city where it was identified—which causes chronic myeloid leukemia. The discovery came in 1960 and established something crucial: cancer has a genetic basis. That finding led eventually to targeted therapies that transformed CML from a death sentence to a manageable chronic condition.[1]
Clinical Programs
Fox Chase provides comprehensive cancer care. Medical oncology, radiation therapy, surgical oncology. That's the foundation. Specialized programs address breast cancer, lung cancer, prostate cancer, blood cancers, and other malignancies. Multidisciplinary tumor boards bring specialists together to develop individualized treatment plans for each patient. Clinical trials enable patients to access experimental treatments while advancing cancer research.[1]
There's a real advantage to specialization. General hospitals can't match the depth of expertise you get when oncologists, surgeons, and radiation therapists focus exclusively on specific cancer types and develop experience from high volumes of similar cases. Support services including genetic counseling, survivorship programs, and palliative care address needs throughout the cancer journey, not just treatment itself.[1]
Temple Health Integration
In 2012, Fox Chase joined Temple Health. The move combined the cancer center's specialized expertise with the health system's broader clinical capabilities and regional reach. It enabled facility investments, faculty recruitment, and program expansion that independent operation might not have supported. Still, Fox Chase maintains its distinct identity and NCI designation within the Temple system.[1]
The integration extended Fox Chase services to Temple's hospitals throughout the region. Patients at Temple hospitals can now access Fox Chase protocols and specialists, while Fox Chase draws on Temple's primary care and specialty services for patients with non-cancer needs. This reflects broader trends toward hospital system consolidation across the country.[1]